Why is P & G Health Ltd falling/rising?

As of 22-Sep, Procter & Gamble Health Ltd's stock price is currently at 6,268.85, reflecting a decline of 75.15 points or 1.18%. The stock's performance today is in line with its sector, although it is trading higher than the 50-day, 100-day, and 200-day moving averages but lower than the 5-day and 20-day moving averages. The stock has experienced a slight decrease of 0.04% over the past week and a more significant drop of 4.64% over the past month, while it has shown strong performance year-to-date with a return of 19.86%. Despite positive indicators such as high management efficiency, a low debt-to-equity ratio, and consistent positive quarterly results, the stock faces challenges with poor long-term growth and a high valuation, which may contribute to its recent price decline.
In the broader market context, the Sensex has increased by 0.46% over the past week, indicating that the stock's short-term performance is lagging behind the benchmark. While Procter & Gamble Health Ltd has outperformed the BSE500 over the last year and three years, the recent drop in investor participation, as evidenced by a 7.79% decrease in delivery volume, suggests a potential lack of confidence among investors. This decline in participation, coupled with the stock's relatively high valuation compared to its peers, may be influencing its current downward price movement despite its historical performance and institutional support.